ARUP Newsroom

Visit booth #915 to explore the latest in diagnostic laboratory testing and discuss your testing needs with ARUP experts.

The U.S. District Court for the Eastern District of Texas today struck down the FDA’s final rule to regulate laboratory-developed tests.

ARUP CEO Andy Theurer leads a group of university students through ARUP’s Automated Core Laboratory.

Jonathan Genzen, MD, PhD, MBA, ARUP’s chief medical officer and senior director of governmental affairs, along with three coauthors, created a detailed resource summarizing existing federal laws and regulations in the context of anatomic pathology.

Benjamin Bradley, MD, PhD, medical director of the ARUP Institute for Research and Innovation in Infectious Disease Genomic Technologies, High Consequence Pathogen Response, Virology, and Molecular Infectious Diseases, participated in a media briefing about the measles virus with the College of American Pathologists.

Research highlights will include applications of RNA sequencing, long-read whole genome sequencing, and cytogenetics in the identification of rare and undiagnosed diseases, confirmation of novel variants, the curation of standardized reports for pharmacogenetics testing, and more.